Related Experiment Video
Updated: Jul 9, 2026
08:47
The Hypoxic Ischemic Encephalopathy Model of Perinatal Ischemia
Published on: November 19, 2008
36.3K
Advances in Neonatal Hypoxic-Ischemic Encephalopathy.
Julia Konrad1, Vann Chau2, Thiviya Selvanathan3
1Department of Pediatric Neurology and Developmental Medicine, Dr. von Hauner Children's Hospital, LMU Munich, Munich, Germany.
Pediatric Clinics of North America
|October 12, 2025
Summary
Hypoxic-ischemic encephalopathy (HIE) is a leading cause of brain injury in newborns. This overview covers HIE investigations, management, and outcomes in term neonates.
Area of Science:
- Neonatal neurology
- Perinatal medicine
- Neurodevelopmental disorders
Background:
- Hypoxic-ischemic encephalopathy (HIE) is the primary cause of neonatal encephalopathy in term infants.
- HIE significantly contributes to global neonatal morbidity and mortality despite advancements in perinatal care.
- Survivors face a high risk of lifelong neurodevelopmental impairments, creating significant burdens.
Purpose of the Study:
- To provide a clinical overview of HIE in term neonates.
- To highlight key investigations and management strategies for HIE.
- To discuss neurodevelopmental outcomes and identify areas for future research.
Main Methods:
- This article presents a clinically-focused review.
- It synthesizes current knowledge on HIE management and outcomes.
- Focuses on investigations, therapeutic interventions, and long-term follow-up.
Main Results:
- HIE diagnosis relies on clinical presentation, neuroimaging, and biomarkers.
- Therapeutic hypothermia is a cornerstone of HIE management.
- Neurodevelopmental outcomes vary, with a significant proportion experiencing impairments.
Conclusions:
- Effective management of HIE requires prompt diagnosis and intervention.
- Long-term neurodevelopmental surveillance is crucial for HIE survivors.
- Further research is needed to improve HIE prevention and treatment strategies.
